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TIMP- 1 produced by cardiac ¿ broblasts improves cardiomyocytes vi-
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Background: Cardiac ¿ broblasts (CF) are the largest cell population in 
the heart. They are involved in physiological and pathological conditions 
like heart failure and remodelling. Preliminary data obtained in our labora-
tory showed that conditioned medium (CM) of CF increases neonatal rat car-
diomyocytes (NRC) viability after a sequence of ischemia reperfusion (I/R). 
In this CM several factors were identi¿ ed and TIMP- 1 (Tissue Inhibitor of 
Metalloproteinase- 1) was the most highly expressed. 
Hypothesis: We hypothesized that TIMP- 1 was implicated in the modula-
tion of cardioprotection against ischemia reperfusion injury.
Method: NRC were isolated from 2 days old Wistar rats and submitted to 
3 hours of simulated ischemia, followed by 21 hours of simulated reperfusion. 
Recombinant protein TIMP- 1 (0.5nM) was added into NRC medium at reper-
fusion. After I/R, cell viability was evaluated using MTT assay. Western blot 
was performed in order to detect Akt and ERK1/2 proteins and their phos-
phorylated forms. LY24002 and PD98059 were used as inhibitors to inves-
tigate PI3K/Akt and ERK1/2 signalling pathway respectively. For in vivo 
experiment, myocardial ischemia reperfusion was induced on C57Bl6 mice 
by coronary artery ligation during 60 minutes through a left thoracotomy. 
Animals (n=8/group) received 5 minutes before reperfusion an IV bolus of 
the drug vehicle or TIMP- 1 mouse recombinant protein at the concentration 
of 0.75μg/kg. Area at risk and area of necrosis were evaluated after 24 hours 
of reperfusion.
Results: We showed that TIMP- 1 increases NRC viability after I/R and 
induces an activation of Akt and ERK 1/2 signalling pathway. Akt and 
ERK1/2 inhibitors reverse this protecting effect. In vivo experiments showed 
that TIMP- 1 reduces infarct size by 50% vs control. 
Conclusion: Our data show that TIMP- 1 protects NRC against ischemia 
reperfusion injury by increasing viability. This cardioprotection could be 
mediated by an activation of Akt and ERK1/2 signalling pathways.
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Myocardial ischemia is a disease that remains highly lethal despite recent 
advanced medical treatment. It is caused by the sudden interruption of coro-
nary À ow by occlusion of the coronary artery, which sequentially causes irre-
versible cardiomyopathy, tissue loss, and scar formation.
Nitric oxide (NO) is vital for the protection against ischaemic heart disease. 
Arginase is up- regulated during I/R and this enzyme compete with NO syn-
thase (NOS) for arginine, the substrate of NO.
We investigated the protective effect of N- omega- hydroxy- nor- L- arginine 
(nor- NOHA), the arginase blockade, whereby inhibition of arginase activity 
increases the bioavailability of NO by shifting utilization of the substrate argi-
nine from arginase to NOS.
Rats were subjected to 30min of coronary artery ligation, followed by 2h of 
reperfusion. The validity of this model was attested by the stability of PaO2, 
PaCO2 and pH recorded before, during and after ligation.
An I.V. administration of nor- NOHA was performed before or after ligation.
The ef¿ cacy of nor- NOHA was assessed by troponin levels, marker of car-
diomyocyte damage, measured before and after the ligation and by infarct size.
The plasma levels of troponin were generally undetectable before the 
induction of ischemia, but during reperfusion, the levels of troponin was equi-
valent in all the ischaemic group with a tendency to decrease for nor- NOHA 
treatment.
Concerning infarct size, nor- NOHA, injected before ischemia, induced a 
signi¿ cant decrease in the infarct size (- 24%), expressed in function of the 
risk area.
In conclusion, nor- NOHA afforded a cardioprotection effect. This ¿ nding 
represents an important and novel mechanism in cardiac I/R injury, and could 
serve as a new therapeutic target in ischaemic heart disease.
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Cardioprotective effects of statins administered during reoxygenation 
is associated with anti apoptotic effects in human myocardium, in vitro
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Introduction: The importance of apoptosis in reperfusion injury is well 
established. We have showed that pravastatin, a statin, administered during 
reoxygenation induced cardioprotection (Anesth Analg 2010;110(suppl.); 
S423). This study investigated the effect of pravastatin during reoxyge-
nation on the expression of markers of apoptosis in human myocardium, 
in vitro.
Methods: After the approval of CPP, right atrial appendages were 
obtained during cannulation for CPB from patients scheduled for cardiac 
surgery. Right atria were pinned in a chamber containing Tyrode’s solu-
tion (34°C, 1 Hz) exposed to 30 min hypoxia and 60min reoxygenation 
(Control), pravastatin was administered throughout the reoxygenation 
(Prava). The protein expression of BAD, phospho- BAD, caspase 3, Pim- 1 
kinase and Bcl- 2 were measured 15min after the start of reoxygenation and 
at the end of reoxygenation period (15min and 60min reox) using Western 
immunoblotting. Statistical comparison was made by analysis of variance.
Results: At 15min reox and 60min reox, pravastatin increase the ratio 
phospho- BAD (Ser112)/BAD total and the level of caspase 3 as com-
pared to the respective Control (P<0.01). At 60min reox, pravastatin abo-
lished the decrease of caspase 3 expression observed in Control, suggesting 
that pravastatin preserve the myocardium against the caspase 3 activation. 
At 60min reox, in Control Bcl- 2 expression was decreased as compared to 
that observed at 15min of reoxygenation (P<0.01). At 60min reox, the level 
of Bcl- 2 was enhanced in presence of pravastatin as compared to respec-
tive Control (P<0.01), suggesting that pravastatin abolished the decrease of 
Bcl- 2 observed in Control. At 15min reox and 60min reox, the Pim- 1 expres-
sion was enhanced in presence of pravastatin as compared to the correspon-
ding Control (P<0.01).
Conclusions: Pravastatin induced cardioprotection is associated to the 
phosphorylation of BAD, the activation of Pim- 1 and Bcl- 2, and maintain of 
the caspase 3 level.
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Introduction: Autophagy is a highly orchestrated cellular process by which 
proteins and organelles are degraded via an elaborate lysosomal pathway. In 
the heart, autophagy occurs at low levels under normal conditions, and during 
stress, dysregulation of this process is responsible for heart dysfunction and 
failure. Although autophagy is enhanced in various pathophysiological condi-
tions, such as during ischemia and reperfusion (IR), whether post- ischemic 
ventricular ¿ brillation (VF) could be involved in its activation has never been 
challenged. Consequently the aim of this work was to study, in hearts subject 
to IR, alterations of activation pathways of autophagy following VF.
Methods: First a myocardial global IR on isolated, Langendorff buffer 
perfused heart was performed on 22 C57BL/6 mice. Autophagy activation 
pathways were then studies in hearts developing VF (VF, n=9) or not VF 
(Ctrl, n=13). In order to evaluate autophagy, LC3B, ATG- 5, ATG- 7, ATG- 12, 
Bcl- 2 and Beclin- 1expressions in LV tissues were evaluated using western 
immunoblotting.
Results and Discussion: In our experiment it has been observed that the 
ratio between LC3B- II and LC3B- I was drastically increased following VF 
pointing out an increase in autophagy by VF. This increase appears to be due 
to an increase in LC3B- II content without change in LC3B- I. No effect of VF 
was observed on the ATG pathway. Indeed, no difference was observed in the 
expression of ATG- 7 and ATG- 5 as well as in the conjugation of ATG- 5 and 
ATG12. A main result of this study was to point out that the activation of auto-
phagy may be due to the increase of Beclin- 1 expression without any change 
in Bcl- 2 content. Consequently the main result of this experiment is to point 
out that occurrence of VF during IR is responsible for an increase in cellular 
autophagy which is the consequence of an increase in Beclin- 1 expression.
